To strengthen the augment, PD-L1 was found to be expressed on tumor cells or CD68+/CD163+ M2 tumor-associated macrophages in MSI CRC patients and was attributed to tumor invasion extension and immune escape (142). The gene discussed is CD274; the disease is neoplasm.